1501 related articles for article (PubMed ID: 28817690)
1. Resveratrol and caloric restriction prevent hepatic steatosis by regulating SIRT1-autophagy pathway and alleviating endoplasmic reticulum stress in high-fat diet-fed rats.
Ding S; Jiang J; Zhang G; Bu Y; Zhang G; Zhao X
PLoS One; 2017; 12(8):e0183541. PubMed ID: 28817690
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol prevents hepatic steatosis and endoplasmic reticulum stress and regulates the expression of genes involved in lipid metabolism, insulin resistance, and inflammation in rats.
Pan QR; Ren YL; Liu WX; Hu YJ; Zheng JS; Xu Y; Wang G
Nutr Res; 2015 Jul; 35(7):576-84. PubMed ID: 26055348
[TBL] [Abstract][Full Text] [Related]
3. Metformin alleviates hepatosteatosis by restoring SIRT1-mediated autophagy induction via an AMP-activated protein kinase-independent pathway.
Song YM; Lee YH; Kim JW; Ham DS; Kang ES; Cha BS; Lee HC; Lee BW
Autophagy; 2015; 11(1):46-59. PubMed ID: 25484077
[TBL] [Abstract][Full Text] [Related]
4. Lack of Additive Effects of Resveratrol and Energy Restriction in the Treatment of Hepatic Steatosis in Rats.
Milton-Laskibar I; Aguirre L; Fernández-Quintela A; Rolo AP; Soeiro Teodoro J; Palmeira CM; Portillo MP
Nutrients; 2017 Jul; 9(7):. PubMed ID: 28696376
[TBL] [Abstract][Full Text] [Related]
5. Involvement of autophagy in the beneficial effects of resveratrol in hepatic steatosis treatment. A comparison with energy restriction.
Milton-Laskibar I; Aguirre L; Etxeberria U; Milagro FI; Martínez JA; Portillo MP
Food Funct; 2018 Aug; 9(8):4207-4215. PubMed ID: 29993072
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol improves hepatic steatosis by inducing autophagy through the cAMP signaling pathway.
Zhang Y; Chen ML; Zhou Y; Yi L; Gao YX; Ran L; Chen SH; Zhang T; Zhou X; Zou D; Wu B; Wu Y; Chang H; Zhu JD; Zhang QY; Mi MT
Mol Nutr Food Res; 2015 Aug; 59(8):1443-57. PubMed ID: 25943029
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of NAMPT aggravates high fat diet-induced hepatic steatosis in mice through regulating Sirt1/AMPKα/SREBP1 signaling pathway.
Wang LF; Wang XN; Huang CC; Hu L; Xiao YF; Guan XH; Qian YS; Deng KY; Xin HB
Lipids Health Dis; 2017 Apr; 16(1):82. PubMed ID: 28449683
[TBL] [Abstract][Full Text] [Related]
8. Resveratrol attenuates hepatic steatosis in high-fat fed mice by decreasing lipogenesis and inflammation.
Andrade JM; Paraíso AF; de Oliveira MV; Martins AM; Neto JF; Guimarães AL; de Paula AM; Qureshi M; Santos SH
Nutrition; 2014; 30(7-8):915-9. PubMed ID: 24985011
[TBL] [Abstract][Full Text] [Related]
9. SIRT1/HSF1/HSP pathway is essential for exenatide-alleviated, lipid-induced hepatic endoplasmic reticulum stress.
Zheng X; Xu F; Liang H; Cao H; Cai M; Xu W; Weng J
Hepatology; 2017 Sep; 66(3):809-824. PubMed ID: 28439947
[TBL] [Abstract][Full Text] [Related]
10. Resveratrol attenuates against high-fat-diet-promoted non-alcoholic fatty liver disease in rats mainly by targeting the miR-34a/SIRT1 axis.
BinMowyna MN; AlFaris NA; Al-Sanea EA; AlTamimi JZ; Aldayel TS
Arch Physiol Biochem; 2024 Jun; 130(3):300-315. PubMed ID: 35254877
[TBL] [Abstract][Full Text] [Related]
11. Testosterone protects high-fat/low-carbohydrate diet-induced nonalcoholic fatty liver disease in castrated male rats mainly via modulating endoplasmic reticulum stress.
Jia Y; Yee JK; Wang C; Nikolaenko L; Diaz-Arjonilla M; Cohen JN; French SW; Liu PY; Lue Y; Lee WP; Swerdloff RS
Am J Physiol Endocrinol Metab; 2018 Apr; 314(4):E366-E376. PubMed ID: 28928235
[TBL] [Abstract][Full Text] [Related]
12. Caffeic acid ameliorates hepatic steatosis and reduces ER stress in high fat diet-induced obese mice by regulating autophagy.
Kim HM; Kim Y; Lee ES; Huh JH; Chung CH
Nutrition; 2018 Nov; 55-56():63-70. PubMed ID: 29960159
[TBL] [Abstract][Full Text] [Related]
13. Gastric bypass surgery is protective from high-fat diet-induced non-alcoholic fatty liver disease and hepatic endoplasmic reticulum stress.
Mosinski JD; Pagadala MR; Mulya A; Huang H; Dan O; Shimizu H; Batayyah E; Pai RK; Schauer PR; Brethauer SA; Kirwan JP
Acta Physiol (Oxf); 2016 Jun; 217(2):141-51. PubMed ID: 26663034
[TBL] [Abstract][Full Text] [Related]
14. Ameliorative effects of lutein on non-alcoholic fatty liver disease in rats.
Qiu X; Gao DH; Xiang X; Xiong YF; Zhu TS; Liu LG; Sun XF; Hao LP
World J Gastroenterol; 2015 Jul; 21(26):8061-72. PubMed ID: 26185377
[TBL] [Abstract][Full Text] [Related]
15. JianPi-QingHua formula attenuates nonalcoholic fatty liver disease by regulating the AMPK/SIRT1/NF-κB pathway in high-fat-diet-fed C57BL/6 mice.
Tian J; Cai M; Jin S; Chen Q; Xu J; Guo Q; Yan Z; Han X; Lu H
Pharm Biol; 2023 Dec; 61(1):647-656. PubMed ID: 37038833
[TBL] [Abstract][Full Text] [Related]
16. Resveratrol Ameliorates Lipid Droplet Accumulation in Liver Through a SIRT1/ ATF6-Dependent Mechanism.
Zhou R; Yi L; Ye X; Zeng X; Liu K; Qin Y; Zhang Q; Mi M
Cell Physiol Biochem; 2018; 51(5):2397-2420. PubMed ID: 30537742
[TBL] [Abstract][Full Text] [Related]
17. Sirtuin1 and autophagy protect cells from fluoride-induced cell stress.
Suzuki M; Bartlett JD
Biochim Biophys Acta; 2014 Feb; 1842(2):245-55. PubMed ID: 24296261
[TBL] [Abstract][Full Text] [Related]
18. The expression of SIRT1 in nonalcoholic fatty liver disease induced by high-fat diet in rats.
Deng XQ; Chen LL; Li NX
Liver Int; 2007 Jun; 27(5):708-15. PubMed ID: 17498258
[TBL] [Abstract][Full Text] [Related]
19. Resveratrol up-regulates hepatic uncoupling protein 2 and prevents development of nonalcoholic fatty liver disease in rats fed a high-fat diet.
Poulsen MM; Larsen JØ; Hamilton-Dutoit S; Clasen BF; Jessen N; Paulsen SK; Kjær TN; Richelsen B; Pedersen SB
Nutr Res; 2012 Sep; 32(9):701-8. PubMed ID: 23084643
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of HMGB1 release via salvianolic acid B-mediated SIRT1 up-regulation protects rats against non-alcoholic fatty liver disease.
Zeng W; Shan W; Gao L; Gao D; Hu Y; Wang G; Zhang N; Li Z; Tian X; Xu W; Peng J; Ma X; Yao J
Sci Rep; 2015 Nov; 5():16013. PubMed ID: 26525891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
